Company Reports Q1 Revenue of $198.3M, Below Expectations
Reports Q1 revenue $198.3M, consensus $200.94M. Chris Reading, Chairman and Chief Executive Officer commented, "I want to begin by thanking our partners and clinical teams for their tremendous care and their continued efforts on behalf of our patients and across several important initiatives this year. These include a partial virtualization of our front desk; company-wide rollout of ambient-listening technology to improve documentation efficiency and allow for more patient-centric interaction; remote therapeutic monitoring for our traditional Medicare patients to facilitate greater home program adherence positively impacting care and outcomes; and targeted cash-based program expansion across our top partnerships impacting care and outcomes as well as overall margin. These initiatives, along with our very important hospital alliance focus, will bear fruit particularly in the second half of the year."
Trade with 70% Backtested Accuracy
Analyst Views on USPH
About USPH
About the author

- Acquisition Deal: U.S. Physical Therapy has acquired a twelve-clinic practice effective July 1, 2026, purchasing a 67% equity interest while existing owners retain 33%, which is expected to significantly enhance the company's market share.
- Patient Visits: The practice generates approximately 112,000 patient visits annually and about $12 million in revenue, further expanding U.S. Physical Therapy's national footprint and enhancing its service capabilities.
- Strategic Integration: COO Graham Reeve stated that the acquisition reflects the company's strategy of combining local expertise with national resources to deliver high-quality care, thereby enhancing customer experience.
- Market Performance: U.S. Physical Therapy's stock has traded between $58.19 and $93.50 over the past year, closing at $71.31, up 3.83%, indicating a positive market reaction to the acquisition.
- Equity Acquisition: U.S. Physical Therapy (USPH) has acquired a 67% equity interest in a physical therapy practice that operates twelve clinics, with the current owners retaining 33%, reflecting the company's proactive strategy to expand its market share.
- Annual Visits and Revenue: The practice generates approximately 112,000 annual visits and $12 million in annual revenue, indicating its stable performance and profitability within the physical therapy sector, laying a solid foundation for USPH's future growth.
- Enhanced Financing Capability: USPH recently announced a $450 million credit facility, which not only supports the funding of this acquisition but also enhances the company's financial flexibility for future expansions and investments.
- Market Outlook: This acquisition further solidifies USPH's position in the physical therapy market, with expectations to improve overall business performance and customer service quality through resource integration and operational optimization.
- Acquisition Expansion: U.S. Physical Therapy announced the acquisition of a twelve-clinic practice effective July 1, 2026, securing a 67% equity interest while the current owners retain 33%, with the practice generating approximately 112,000 annual visits and $12 million in revenue, thereby solidifying its market position.
- Market Coverage Increase: This acquisition expands U.S. Physical Therapy's footprint from 44 to 45 states, demonstrating the company's commitment to delivering high-quality physical therapy services nationwide while leveraging national resources and expertise to drive growth.
- Community Relationship Enhancement: The new partners are recognized for delivering exceptional clinical care and building trusted relationships within their communities, which will help U.S. Physical Therapy establish a strong foundation in the new state and enhance patient care quality.
- Growth Strategy: The Chief Operating Officer stated that this expansion represents an important step in the company's ongoing growth, reflecting U.S. Physical Therapy's leadership position in the physical therapy industry and confidence in future developments.
- Helios Performance Exceeds Expectations: Helios Technologies (NYSE:HLIO) reported first-quarter 2026 results that surpassed analyst expectations, leading to a 12.5% stock increase and an upward revision of its full-year outlook, indicating strong market performance and future growth potential.
- DraftKings Rating Reaffirmed: DraftKings (NASDAQ:DKNG) saw a 2.2% stock rise after Truist Securities reiterated a Buy rating on its shares, reflecting analysts' confidence in the company's future profitability and potentially attracting more investor interest.
- CACI Secures Major Contract: CACI International (NYSE:CACI) experienced a 3.5% stock increase after securing a $113.8 million contract from the U.S. Navy, which not only strengthens its revenue base but also enhances its market position in defense and IT solutions.
- U.S. Physical Therapy Continues Growth: U.S. Physical Therapy (NYSE:USPH) rose by 4.4% as it reported strong first-quarter 2026 results and confirmed its full-year financial outlook, demonstrating robust growth in the physical therapy market and solid customer demand.
- Industry Environment Analysis: Chris Reading, CEO of U.S. Physical Therapy, discussed the overall operating environment in healthcare at the 2026 BofA Securities Healthcare Conference, emphasizing the company's ability to navigate challenges in a changing market, aimed at boosting investor confidence.
- Key Initiatives Overview: Reading outlined the company's key initiatives in physical therapy and industrial injury prevention, indicating a commitment to enhancing customer experience through innovative services, thereby driving business growth and increasing market share.
- Business Scale and Coverage: Founded in 1990, U.S. Physical Therapy currently owns and/or manages 784 outpatient physical therapy clinics across 44 states, providing preventative and post-operative care for various orthopedic-related disorders and sports injuries, showcasing its extensive influence in the industry.
- Comprehensive Service Capabilities: The company also offers onsite services including injury prevention, rehabilitation, and performance optimization, aimed at enhancing employee efficiency and health, further solidifying its market position.
- Oversold Status Analysis: U.S. Physical Therapy, Inc. (USPH) has an RSI of 20.2, significantly below the oversold threshold of 30, indicating that the recent decline in stock price may be nearing exhaustion, attracting investors looking for buying opportunities.
- Price Volatility Impact: USPH's stock price fell to a low of $58.55 on Thursday, contrasting sharply with its recent price of $73.65, which translates to an annualized dividend yield of 2.50%, suggesting a higher yield potential for dividend investors at current levels.
- Dividend History Consideration: While dividends are not always predictable, investors should examine USPH's dividend history to assess the likelihood of the recent dividend being sustained, providing a basis for future investment decisions.
- Market Sentiment Shift: Given the current oversold condition, investors may reassess USPH's investment value, especially as market sentiment shifts towards bullishness, potentially leading to increased capital inflow into the stock.










